drugset / Trial / NCT02301000

IMT for Primary Clostridium Difficile Infection

NCT02301000

Phase 2/3 Terminated 21 enrolled Oslo University Hospital University of Oslo · collab
RandomizedParallel-groupSingle-blindTreatment

Summary

This is a randomized controlled trial to compare the effect of a 10-day course of per oral metronidazole versus a one-time rectal instillation of an anaerobically cultivated human intestinal microbiota for the treatment of a first occurrence of Clostridium difficile infection (CDI). Recurrent CDI is common after standard antibiotic treatment. We hypothesize that the instillation of a healthy intestinal microbiota will be more effective in inducing a durable cure than metronidazole for primary CDI.

Timeline

Start
2015-02-22
Primary completion
2017-11-16
Completion
2017-11-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Anaerobically Cultivated Human Intestinal Microbiota Other / unclassified 60 ml Rectal
Comparator Metronidazole Small molecule 400 mg Oral